Predictmedix Inc. Announces LOI to Acquire Symp2pass Inc.

TORONTO, March 23, 2021 (GLOBE NEWSWIRE) -- Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) ("Predictmedix" or the "Company") is pleased to announce it has entered into a letter of intent (the "LOI"), to acquire Symp2Pass Inc. ("Symp2pass") (the "Acquisition").